News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Eli Lilly and Company Turns to Chi-Med - Paid Up to $29M in So-Called “Milestone Fees”
August 20, 2007
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Eli Lilly, the global pharmaceuticals giant behind blockbuster drugs including the anti-depressant Prozac, is turning to ancient Chinese remedies for a new pipeline of treatments.
Twitter
LinkedIn
Facebook
Email
Print
Alliances
Asia
Eli Lilly and Company
MORE ON THIS TOPIC
Layoff Tracker
Amgen Trims Horizon Subsidiary, f5 Shuts Down
March 11, 2026
·
33 min read
·
BioSpace Editorial Staff
Podcast
Prasad Out at FDA, Lawmaker Takes Action on Rare Disease Rejections and a Spate of Obesity Data
March 11, 2026
·
1 min read
·
Heather McKenzie
C-suite
BioNTech Founders To Leave Famed mRNA Biotech for New Venture
March 10, 2026
·
2 min read
·
Annalee Armstrong
Manufacturing
Cell and Gene Therapy Manufacturing Market To Skyrocket to $146B by 2032
March 10, 2026
·
3 min read
·
Nick Paul Taylor
